Invitae Corporation Cash and Cash Equivalents 2011-2026 | NVTA

Annual Cash and Cash Equivalents Invitae Corporation

2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
257 M	923 M	131 M	151 M	112 M	12.1 M	66.8 M	73.2 M	107 M	43.1 M	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
923 M	12.1 M	188 M

Quarterly Cash and Cash Equivalents Invitae Corporation

2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
158 M	223 M	161 M	257 M	217 M	304 M	325 M	923 M	922 M	1.11 B	194 M	131 M	125 M	125 M	125 M	151 M	151 M	151 M	151 M	112 M	112 M	112 M	112 M	12.1 M	12.1 M	12.1 M	12.1 M	66.8 M	66.8 M	66.8 M	66.8 M	73.2 M	73.2 M	73.2 M	73.2 M	107 M	107 M	107 M	107 M	43.1 M	-	-	-	21.8 M	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
1.11 B	12.1 M	182 M

Cash and Cash Equivalents of other stocks in the Diagnostics research industry

Issuer	Cash and Cash Equivalents	Price	% 24h	Market Cap	Country
Akumin AKU	59.4 M	-	-17.87 %	$ 25.9 M	Canada
Burning Rock Biotech Limited BNR	1.9 B	$ 16.65	-	$ 179 M	China
Centogene N.V. CNTG	19.1 M	-	-6.23 %	$ 30.6 M	Germany
Castle Biosciences CSTL	120 M	$ 23.93	-3.12 %	$ 665 M	USA
Agilent Technologies A	1.48 B	$ 113.27	-1.39 %	$ 34.4 B	USA
Accelerate Diagnostics AXDX	34.9 M	-	-61.36 %	$ 2.46 M	USA
Aspira Women's Health AWH	1.76 M	-	-6.19 %	$ 10.5 M	USA
Biocept BIOC	12.9 M	-	-13.05 %	$ 7.29 M	USA
Chembio Diagnostics CEMI	18.2 M	-	0.22 %	$ 16.8 M	USA
Neogen Corporation NEOG	129 M	$ 9.11	-2.52 %	$ 1.98 B	USA
Check-Cap Ltd. CHEK	7.7 M	-	-	$ 9.42 M	Israel
Co-Diagnostics CODX	11.9 M	$ 1.59	-2.72 %	$ 2.12 M	USA
Koninklijke Philips N.V. PHG	2.79 B	$ 25.48	-6.05 %	$ 20 B	Niderland
Personalis PSNL	91.4 M	$ 5.26	-4.36 %	$ 312 M	USA
CareDx, Inc CDNA	65.4 M	$ 19.91	-9.15 %	$ 1.06 B	USA
DermTech DMTK	36.7 M	-	-11.32 %	$ 2.94 M	USA
Enzo Biochem ENZ	52.4 M	-	-8.98 %	$ 14.8 K	USA
Exact Sciences Corporation EXAS	956 M	-	-	$ 19.8 B	USA
Fulgent Genetics FLGT	55.1 M	$ 14.9	-2.61 %	$ 451 M	USA
Illumina ILMN	1.13 B	$ 124.12	-2.21 %	$ 19.7 B	USA
Global Cord Blood Corporation CO	6.66 B	-	-	$ 399 M	China
Genetic Technologies Limited GENE	11.7 M	-	-	$ 7.1 B	Australia
Genetron Holdings Limited GTH	176 M	-	0.12 %	$ 80.1 M	China
Trinity Biotech plc TRIB	5.17 M	$ 0.61	-1.21 %	$ 61.9 M	Irlanda
Charles River Laboratories International CRL	214 M	$ 168.25	0.88 %	$ 8.34 B	USA
Twist Bioscience Corporation TWST	183 M	$ 57.54	-2.72 %	$ 3.44 B	USA
HTG Molecular Diagnostics HTGM	12.2 M	-	-20.0 %	$ 1.06 M	USA
Guardant Health GH	378 M	$ 82.57	-0.66 %	$ 10.4 B	USA
Lantheus Holdings LNTH	359 M	$ 80.89	-3.18 %	$ 5.46 B	USA
Heska Corporation HSKA	157 M	-	-	$ 1.31 B	USA
Interpace Biosciences IDXG	2.5 M	$ 1.96	1.5 %	$ 8.67 M	USA
Senseonics Holdings SENS	40.2 M	$ 6.86	-4.44 %	$ 286 M	USA
QIAGEN N.V. QGEN	598 M	-	-	$ 10.6 B	Niderland
Medpace Holdings MEDP	497 M	$ 410.67	0.22 %	$ 11.8 B	USA
Biomerica BMRA	2.4 M	$ 2.16	-1.47 %	$ 4.96 M	USA
Motus GI Holdings MOTS	4.96 M	-	-34.28 %	$ 263 K	Israel
ICON Public Limited Company ICLR	752 M	$ 114.53	11.74 %	$ 9.45 B	Irlanda
Laboratory Corporation of America Holdings LH	532 M	$ 255.97	-1.39 %	$ 21.3 B	USA
NeoGenomics NEO	160 M	$ 9.18	1.72 %	$ 1.18 B	USA
Celcuity CELC	166 M	$ 119.79	-0.24 %	$ 5.6 B	USA
National Research Corporation NRC	4.14 M	$ 15.0	-10.93 %	$ 336 M	USA
Myriad Genetics MYGN	150 M	$ 4.75	-1.96 %	$ 440 M	USA
Natera NTRA	466 M	$ 194.2	-2.98 %	$ 19.1 B	USA
Quest Diagnostics Incorporated DGX	420 M	$ 188.26	-3.48 %	$ 20.9 B	USA
Exagen XGN	32.2 M	$ 2.73	-	$ 58.9 M	USA
OpGen OPGN	1.31 M	-	-16.95 %	$ 1.54 M	USA